Giant cells: Contradiction to two-hit model of tuber formation?

Cellular and Molecular Neurobiology

Volumn 25, Issue 5, 2005, Pages 795-806

  Jozwiak, Jaroslaw ^a   Jozwiak, Sergiusz ^b  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

Author keywords

Giant cells; Loss of heterozygosity; SEGA

Indexed keywords

HAMARTIN; TUBERIN;

ALLELE; BRAIN INJURY; CELL LINEAGE; GENE DELETION; GENE EXPRESSION; GENE MUTATION; GIANT CELL; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MOLECULAR MECHANICS; NEURAL TUBE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; TUBEROUS SCLEROSIS;

ANIMALS; BRAIN NEOPLASMS; GIANT CELLS; HUMANS; TUBEROUS SCLEROSIS;

EID: 23844434440     PISSN: 02724340     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10571-005-4932-z     Document Type: Review

References (67)

1. Anderson, A. E., Yang, X., and Young, R. H. (2002). Epithelioid angiomyolipoma of the ovary: A case report and literature review. Int. J. Gynecol. Pathol. 21:69-73.
2. Bender, B. L., and Yunis, E. J. (1980). Central nervous system pathology of tuberous sclerosis in children. Ultrastruct. Pathol. 1:287-299.
3. Brown, J. P., Couillard-Despres, S., Cooper-Kuhn, C. M., Winkler, J., Aigner, L., and Kuhn, H. G. (2003). Transient expression of doublecortin during adult neurogenesis. J. Comp. Neurol. 467:1-10.
4. Chan, J. A., Zhang, H., Roberts, P. S., Jozwiak, S., Wieslawa, G., Lewin-Kowalik, J., Kotulska, K., and Kwiatkowski, D. J. (2004). Pathogenesis of tuberous sclerosis subependymal giant cell astrocytomas: Biallelic inactivation of TSC1 or TSC2 leads to mTOR activation. J. Neuropathol. Exp. Neurol. 63: 1236-1242.
5. Cheadle, J. P., Reeve, M. P., Sampson, J. R., and Kwiatkowski, D. J. (2000). Molecular genetic advances in tuberous sclerosis. Hum. Genet. 107:97-114.
6. Chou, T. M., and Chou, S. M. (1989). Tuberous sclerosis in the premature infant: A report of a case with immunohistochemistry on the CNS. Clin. Neuropathol. 8:45-52.
7. Cil, A. P., Haberal, A., Hucumenoglu, S., Kovalak, E. E., and Gunes, M. (2004). Angiomyolipoma of the uterus associated with tuberous sclerosis: Case report and review of the literature. Gynecol. Oncol. 94:593-596.
8. Dabora, S. L., Jozwiak, S., Franz, D. N., Roberts, P. S., Nieto, A., Chung, J., Choy, Y. S., Reeve, M. P., Thiele, E., Egelhoff, J. C., Kasprzyk-Obara, J., Domanska-Pakiela, D., and Kwiatkowski, D. J. (2001). Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs. Am. J. Hum. Genet. 68:64-80.
9. European Tuberous Sclerosis Consortium. (1993). Identification and characterization of the tuberous sclerosis gene on chromosome 16. The European Chromosome 16 Tuberous Sclerosis Consortium. Cell 75:1305-1315.
10. Guha, A. (1998). Ras activation in astrocytomas and neurofibromas. Can. J. Neurol. Sci. 25:267-281.
11. Gyure, K. A., and Prayson, R. A. (1997). Subependymal giant cell astrocytoma: A clinicopathologic study with HMB45 and MIB-1 immunohistochemical analysis. Mod. Pathol. 10:313-317.
12. Hall, J. G. (1988). Review and hypotheses: Somatic mosaicism: observations related to clinical genetics. Am. J. Hum. Genet. 43:355-363.
13. Henske, E. P., Scheithauer, B. W., Short, M. P., Wollmann, R., Nahmias, J., Hornigold, N., van Slegtenhorst, M., Welsh, C. T., and Kwiatkowski, D. J. (1996). Allelic loss is frequent in tuberous sclerosis kidney lesions but rare in brain lesions. Am. J. Hum. Genet. 59:400-406.
14. Henske, E. P., Wessner, L. L., Golden, J., Scheithauer, B. W., Vortmeyer, A. O., Zhuang, Z., Klein-Szanto, A. J., Kwiatkowski, D. J., and Yeung, R. S. (1997). Loss of tuberin in both subependymal giant cell astrocytomas and angiomyolipomas supports a two-hit model for the pathogenesis of tuberous sclerosis tumors. Am. J. Pathol. 151:1639-1647.
15. Hino, A., Hirokawa, M., Takamura, K., and Sano, T. (2002). Imprint cytology of epithelioid angiomyolipoma in a patient with tuberous sclerosis. A case report. Acta Cytol. 46:545-549.
16. Hirose, T., Scheithauer, B. W., Lopes, M. B., Gerber, H. A., Altermatt, H. J., Hukee, M. J., VandenBerg, S. R., and Charlesworth, J. C. (1995). Tuber and subependymal giant cell astrocytoma associated with tuberous sclerosis: An immunohistochemical, ultrastructural, and immunoelectron and microscopic study. Acta Neuropathol. (Berl). 90:387-399.
17. Inoki, K., Li, Y., Xu, T., and Guan, K. L. (2003). Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling. Genes Dev. 17:1829-1834.
18. Jansen, F. E., Notenboom, R. G., Nellist, M., Goedbloed, M. A., Halley, D. J., de Graan, P. N., and van Nieuwenhuizen, O. (2004). Differential localization of hamartin and tuberin and increased S6 phosphorylation in a tuber. Neurology 63:1293-1295.
19. Jay, V., Edwards, V., and Rutka, J. T. (1993). Crystalline inclusions in a subependymal giant cell tumor in a patient with tuberous sclerosis. Ultrastruct. Pathol. 17:503-513.
20. Ji, Y., Zhu, X., Xu, J., Zhou, J., Tan, Y., Wang, J., Fan, J., and Zhou, Y. (2001). Hepatic angiomyolipoma: A clinicopathologic study of 10 cases. Chin. Med. J. (Engl). 114:280-285.
21. Johnson, M. W., Kerfoot, C., Bushnell, T., Li, M., and Vinters, H. V. (2001). Hamartin and tuberin expression in human tissues. Mod. Pathol. 14:202-210.
22. Jones, A. C., Shyamsundar, M. M., Thomas, M. W., Maynard, J., Idziaszczyk, S., Tomkins, S., Sampson, J. R., and Cheadle, J. P. (1999). Comprehensive mutation analysis of TSC1 and TSC2-and phenotypic correlations in 150 families with tuberous sclerosis. Am. J. Hum. Genet. 64:1305-1315.
23. Jozwiak, S., Dabora, S., Kasprzyk-Obara, J., Domanska-Pakiela, D., and Grajkowska, W. (2001). Tests for loss of heterozygosity in tuberous sclerosis. Przegl. Lek. 58 (Suppl. 1):12-15.
24. Jozwiak, S., Goodman, M., and Lamm, S. H. (1998). Poor mental development in patients with tuberous sclerosis complex: Clinical risk factors. Arch. Neurol. 55:379-384.
25. Jozwiak, S., Kwiatkowski, D., Kotulska, K., Larysz-Brysz, M., Lewin-Kowalik, J., Grajkowska, W., and Roszkowski, M. (2004). Tuberin and hamartin expression is reduced in the majority of subependymal giant cell astrocytomas in tuberous sclerosis complex consistent with a two-hit model of pathogenesis. J. Child. Neurol. 19:102-106.
26. Knowles, M. A., Habuchi, T., Kennedy, W., and Cuthbert-Heavens, D. (2003). Mutation spectrum of the 9q34 tuberous sclerosis gene TSC1 in transitional cell carcinoma of the bladder. Cancer Res. 63:7652-7656.
27. Knudson, A. G. (1971). Mutation and cancer: Statistical study of retinoblastoma. Proc. Natl. Acad. Sci. U.S.A. 68:820-823.
28. Kwiatkowska, J., Wigowska-Sowinska, J., Napierala, D., Slomski, R., and Kwiatkowski, D. J. (1999). Mosaicism in tuberous sclerosis as a potential cause of the failure of molecular diagnosis. N. Engl. J. Med. 340:703-707.
29. Kwiatkowski, D. J. (2003). Tuberous sclerosis: From tubers to mTOR. Ann. Hum. Genet. 67:87-96.
30. Laeng, R. H., Scheithauer, B. W., and Altermatt, H. J. (1998). Anti-neuronal nuclear autoantibodies, types 1 and 2: Their utility in the study of tumors of the nervous system. Acta Neuropathol. (Berl). 96:329-339.
31. Lamb, R. F., Roy, C., Diefenbach, T. J., Vinters, H. V., Johnson, M. W., Jay, D. G., and Hall, A. (2000). The TSC1 tumour suppressor hamartin regulates cell adhesion through ERM proteins and the GTPase Rho. Nat. Cell Biol. 2:281-287.
32. Lantuejoul, S., Ferretti, G., Negoescu, A., Parent, B., and Brambilla, E. (1997). Multifocal alveolar hyperplasia associated with lymphangioleiomyomatosis in tuberous sclerosis. Histopathology. 30:570-575.
33. Lee, A., Maldonado, M., Baybis, M., Walsh, C. A., Scheithauer, B., Yeung, R., Parent, J., Weiner, H. L., and Crino, P. B. (2003). Markers of cellular proliferation are expressed in cortical tubers. Ann Neurol. 53:668-673.
34. Lee, L., Sudentas, P., Donohue, B., Asrican, K., Worku, A., Walker, V., Sun, Y., Schmidt, K., Albert, M. S., El-Hashemite, N., Lader, A. S., Onda, H., Zhang, H., Kwiatkowski, D. J., and Dabora, S. L. (2005). Efficacy of a rapamycin analog (CCI-779) and IFN-gamma in tuberous sclerosis mouse models. Genes Chromosomes Cancer 42:213-227.
35. Menchine, M., Emelin, J. K., Mischel, P. S., Haag, T. A., Norman, M. G., Pepkowitz, S. H., Welsh, C. T., Townsend, J. J., and Vinters, H. V. (1996). Tissue and cell-type specific expression of the tuberous sclerosis gene, TSC2, in human tissues. Mod. Pathol. 9:1071-1080.
36. Meikle, L., McMullen, J. R., Sherwood, M. C., Lader, A. S., Walker, V., Chan, J. A., and Kwiatkowski, D. J. (2005). A mouse model of cardiac rhabdomyoma generated by loss of TSC1 in ventricular myocytes. Hum. Mol. Genet. 14:429-435.
37. Mizuguchi, M., Mori, M., Nozaki, Y., Momoi, M. Y., Itoh, M., Takashima, S., and Hino, O. (2004). Absence of allelic loss in cytomegalic neurons of cortical tuber in the Eker rat model of tuberous sclerosis. Acta Neuropathol. (Berl). 107:47-52.
38. Mizuguchi, M., and Takashima, S. (2001). Neuropathology of tuberous sclerosis. Brain Dev. 23:508-515.
39. Mizuguchi, M., Yamanouchi, H., Becker, L. E., Itoh, M., and Takashima, S. (2002). Doublecortin immunoreactivity in giant cells of tuberous sclerosis and focal cortical dysplasia. Acta Neuropathol. (Berl). 104:418-424.
40. Niida, Y., Stemmer-Rachamimov, A. O., Logrip, M., Tapon, D., Perez, R., Kwiatkowski, D. J., Sims, K., MacCollin, M., Louis, D. N., and Ramesh, V. (2001). Survey of somatic mutations in tuberous sclerosis complex (TSC) hamartomas suggests different genetic mechanisms for pathogenesis of TSC lesions. Am. J. Hum. Genet. 69:493-503.
41. Onda, H., Crino, P. B., Zhang, H., Murphey, R. D., Rastelli, L., Gould Rothberg, B. E., and Kwiatkowski, D. J. (2002). TSC2 null murine neuroepithelial cells are a model for human tuber giant cells, and show activation of an mTOR pathway. Mol. Cell Neurosci. 21:561-574.
42. Park, S. H., Pepkowitz, S. H., Kerfoot, C., De Rosa, M. J., Poukens, V., Wienecke, R., DeClue, J. E., and Vinters, H. V. (1997). Tuberous sclerosis in a 20-week gestation fetus: Immunohistochemical study. Acta Neuropathol. (Berl). 94:180-186.
43. Plank, T. L., Logginidou, H., Klein-Szanto, A., and Henske, E. P. (1999). The expression of hamartin, the product of the TSC1 gene, in normal human tissues and in TSC1- and TSC2-linked angiomyolipomas. Mod. Pathol. 12:539-545.
44. Povey, S., Burley, M. W., Attwood, J., Benham, F., Hunt, D., Jeremiah, S. J., Franklin, D., Gillett, G., Malas, S., Robson, E. B., Tippett, P., Edwards, J. H., Kwiatkowski, D. J., Super, M., Mueller, R., Fryer, A., Clarke, A., Webb, D., and Osborne, J. (1994). Two loci for tuberous sclerosis: One on 9q34 and one on 16p13. Ann. Hum. Genet. 58:107-127.
45. Ramesh, V. (2003). Aspects of tuberous sclerosis complex (TSC) protein function in the brain. Biochem. Soc. Trans. 31:579-583.
46. Ribalta, T., Lloreta, J., Munne, A., Serrano, S., and Cardesa, A. (2000). Malignant pigmented clear cell epithelioid tumor of the kidney: Clear cell ("sugar") tumor versus malignant melanoma. Hum. Pathol. 31:516-519.
47. Roberts, P. S., Ramesh, V., Dabora, S., Kwiatkowski, D. J. (2003). A 34 bp deletion within TSC2 is a rare polymorphism, not a pathogenic mutation. Ann. Hum. Genet. 67:495-503.
48. Roske, B., Stoltenburg, G., Baier, P. M., Konig, R., and Schlote, W. (2003). Tuberous sclerosis complex with disseminated telencephalic distribution of atypical cells and their relation to corticogenesis. Clin. Neuropathol. 22:119-128.
49. Roszkowski, M., Drabik, K., Barszcz, S., and Jozwiak, S. (1995). Surgical treatment of intraventricular tumors associated with tuberous sclerosis. Childs Nerv. Syst. 11:335-339.
50. Roux, P. P., Ballif, B. A., Anjum, R., Gygi, S. P., and Blenis, J. (2004). Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase. Proc. Natl. Acad. Sci. U.S.A. 101:13489-13494.
51. Sampson, J. R., Maheshwar, M. M., Aspinwall, R., Thompson, P., Cheadle, J. P., Ravine, D., Roy, S., Haan, E., Bernstein, J., and Harris, P. C. (1997). Renal cystic disease in tuberous sclerosis: Role of the polycystic kidney disease 1 gene. Am. J. Hum. Genet. 61:843-851.
52. Sharma, M. C., Ralte, A. M., Gaekwad, S., Santosh, V., Shankar, S. K., and Sarkar, C. (2004). Subependymal giant cell astrocytoma - a clinicopathological study of 23 cases with special emphasis on histogenesis. Pathol. Oncol. Res. 10:219-224.
53. van Slegtenhorst, M., de Hoogt, R., Hermans, C., Nellist, M., Janssen, B., Verhoef, S., Lindhout, D., van den Ouweland, A., Halley, D., Young, J., Burley, M., Jeremiah, S., Woodward, K., Nahmias, J., Fox, M., Ekong, R., Osborne, J., Wolfe, J., Povey, S., Snell, R. G., Cheadle, J. P., Jones, A. C., Tachataki, M., Ravine, D., Sampson, J. R., Reeve, M. P., Richardson, P., Wilmer, F., Munro, C., Hawkins, T. L., Sepp, T., Ali, J. B. M., Ward, S., Green, A. J., Yates, J. R. W., Kwiatkowska, J., Henske, E. P., Short, M. P., Haines, J. H., Jozwiak, S., and Kwiatkowski, D. J. (1997). Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science. 277:805-808.
54. Soucek, T., Pusch, O., Wienecke, R., DeClue, J. E., and Hengstschlager, M. (1997). Role of the tuberous sclerosis gene-2 product in cell cycle control. Loss of the tuberous sclerosis gene-2 induces quiescent cells to enter S phase. J. Biol. Chem. 272:29301-29308.
55. Takahashi, D. K., Dinday, M. T., Barbaro, N. M., and Baraban, S. C. (2004). Abnormal cortical cells and astrocytomas in the Eker rat model of tuberous sclerosis complex. Epilepsia. 45:1525-1530.
56. Telfeian, A. E., Judkins, A., Younkin, D., Pollock, A. N., and Crino, P. (2004). Subependymal giant cell astrocytoma with cranial and spinal metastases in a patient with tuberous sclerosis. Case report. J. Neurosurg. Spine. 100:498-500.
57. Trombley, I. K., and Mirra, S. S. (1981). Ultrastructure of tuberous sclerosis: Cortical tuber and subependymal tumor. Ann. Neurol. 9:174-181.
58. +/- cells. Oncogene 21:4050-4059.
59. Verhoef, S., Bakker, L., Tempelaars, A. M., Hesseling-Janssen, A. L., Mazurczak, T., Jozwiak, S., Fois, A., Bartalini, G., Zonnenberg, B. A., van Essen, A. J., Lindhout, D., Halley, D. J., and van den Ouweland, A. M. (1999). High rate of mosaicism in tuberous sclerosis complex. Am. J. Hum. Genet. 64:1632-1637.
60. Weeks, D. A., Chase, D. R., and Malott, R. L. (1994). HMB-45 staining in angiomyolipoma, cardiac rhabdomyoma, other mesenchymal processes and tuberous sclerosis associated brain lesions. Int. J. Surg. Pathol. 1:191-198.
61. Wienecke, R., Konig, A., and DeClue, J. E. (1995). Identification of tuberin, the tuberous sclerosis-2 product. Tuberin possesses specific Rap1GAP activity. J. Biol. Chem. 270:16409-16414.
62. Wilson, P. J., Ramesh, V., Kristiansen, A., Bove, C., Jozwiak, S., Kwiatkowski, D. J., Short, M. P., and Haines, J. L. (1996). Novel mutations detected in the TSC2 gene from both sporadic and familial TSC patients. Hum. Mol. Genet. 5:249-256.
63. Wolf, H. K., Normann, S., Green, A. J., von Bakel, I., Blumcke, I., Pietsch, T., Wiestler, O. D., and von Deimling, A. (1997). Tuberous sclerosis-like lesions in epileptogenic human neocortex lack allelic loss at the TSC1 and TSC2 regions. Acta Neuropathol. (Berl.). 93:93-96.
64. Xiao, G. H., Shoarinejad, F., Jin, F., Golemis, E. A., and Yeung, R. S. (1997). The tuberous sclerosis 2 gene product, tuberin, functions as a Rab5 GTPase activating protein (GAP) in modulating endocytosis. J. Biol. Chem. 272:6097-6100.
65. Yagishita, A., and Arai N. (1999). Cortical tubers without other stigmata of tuberous sclerosis: imaging and pathological findings. Neuroradiology 41:428-432.
66. Yamanouchi, H., Jay, V., Rutka, J. T., Takashima, S., and Becker, L. E. (1997). Evidence of abnormal differentiation in giant cells of tuberous sclerosis. Pediatr. Neurol. 17:49-53.
67. Zhang, Y., Gao, X., Saucedo, L. J., Ru, B., Edgar, B. A., and Pan, D. (2003). Rheb is a direct target of the tuberous sclerosis tumour suppressor proteins. Nat. Cell Biol. 5:578-581.